Optimal TTM Tailoring for Population Cessation

Summary

This study explored optimal tailoring strategies for population tobacco cessation in 4 treatment groups and a control group over 24 months. Transtheoretical model (TTM) tailored feedback on all 14 variables has been found to be a robust population cessation strategy across studies. This proposal sought to find a subset of these variables that is optimal for tailoring, both minimizing response burden while maximizing effectiveness. Addiction variables have been demonstrated to predict smoking outcomes across studies as well, so we will integrate tailored feedback using TTM and addiction variables into an enhanced tailoring group. Optimally tailored feedback that both helps unmotivated smokers reduce their addiction and helps motivated smokers quit could lead to a breakthrough in population cessation.

Conditions

• Smoking Cessation

Interventions

BEHAVIORAL

Stage-Tailored Manual

Manual with 5 sections for each Stage of change delivered at baseline

BEHAVIORAL

Stage Tailored Feedback Report

Tailored printed feedback reports based on assessments of stages of change were delivered at baseline, 6 months and 12 months.

BEHAVIORAL

Moderate TTM-Tailored Feedback Report

Tailored printed feedback report based on assessment of stages of change, Pros, Cons, and Temptations were delivered at baseline, 6 months and 12 months.

BEHAVIORAL

Full TTM-Tailored Feedback Report

Tailored print feedback report based on assessment of Stages, Pros, Cons, Temptations, 10 Processes of Change were delivered at baseline, 6 months and 12 months.

BEHAVIORAL

Enhanced TTM+Addiction Tailored Feedback Report

Tailored print feedback report based on assessment of Addiction level (# cigarettes/day),Stages, Pros, Cons, Temptations, 10 Processes of Change were delivered at baseline, 6 months and 12 months.

Sponsors & Collaborators

• University of Rhode Island

  lead OTHER

Principal Investigators

• Colleen A Redding, Ph.D. · University of Rhode Island

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

FACTORIAL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2009-02-28

Primary Completion

2012-06-30

Completion

2012-06-30

Countries

• United States

Study Locations